Menu Search

Company Announcements

Dow Inc

Dow reports second quarter 2025 results

MIDLAND, Mich. , July 24, 2025 /PRNewswire/ -- Dow (NYSE: DOW):

2Q25 FINANCIAL HIGHLIGHTS

  • Net sales were $10.1 billion, down 7% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 3%, as seasonally higher demand in Performance Materials & Coatings was more than offset by declines across the other operating segments.
  • Volume decreased 1% year-over-year, as gains in the U.S. and Canada were more than offset by declines in Europe, the Middle East, Africa and India (EMEAI). Sequentially, volume decreased 2%, as seasonally driven gains in Performance Materials & Coatings, including downstream silicones growth, were more than offset by declines in Packaging & Specialty Plastics. These declines reflect lower merchant ethylene sales arising from the recent startup of the Company's Poly-7 polyethylene asset in the U.S. Gulf Coast, unlocking the full value of integration going forward.
  • Local price was down 7% versus the year-ago period, reflecting declines in all regions and operating segments. Sequentially, local price was down 3%.
  • GAAP net loss was $801 million. Op. EBIT1 was a loss of $21 million, down $840 million year-over-year, primarily driven by lower prices and equity earnings. Sequentially, Op. EBIT was down $251 million, as tailwinds from currency and the Company's cost reduction program were more than offset by declines in Packaging & Specialty Plastics from lower integrated margins.
  • GAAP loss per share was $1.18; operating earnings per share (EPS)1 was a loss of $0.42, compared to earnings of $0.68 in the year-ago period and earnings of $0.02 in the prior quarter. Op. EPS excludes significant items totaling $0.76 per share, primarily driven by restructuring program severance and related benefit costs and asset related charges, including recently announced European portfolio actions.
  • Cash provided by operating activities – continuing operations was negative $470 million, down $1.3 billion year-over-year and down $574 million sequentially, led by lower earnings from margin compression.
  • Returns to shareholders totaled $496 million of dividends in the quarter.

CEO QUOTE
"This quarter the Dow team advanced several aggressive actions in response to the lower-for-longer earnings environment that our industry is facing, amplified by recent trade and tariff uncertainties. We are delivering near-term cash support and earnings growth levers, which we anticipate will total more than $6 billion by 2026. We are also focused on improving margins and optimizing our global portfolio in the face of continued weak macroeconomic conditions, as evidenced by our recent European portfolio actions," said Jim Fitterling, Dow chair and CEO. "We are also adjusting our dividend to ensure we maintain a balanced capital allocation framework. We remain committed to targeting a competitive dividend across the economic cycle. The actions we are taking provide additional financial flexibility to help guarantee we maximize shareholder value, both in the current environment and as the industry recovers."

SUMMARY FINANCIAL RESULTS


Three Months Ended Jun 30

Three Months Ended Mar 31

In millions, except per share amounts

2Q25

2Q24

vs. SQLY

[B / (W)]

1Q25

vs. PQ

[B / (W)]

Net Sales

$10,104

$10,915

$(811)

$10,431

$(327)

GAAP Income (Loss) Net of Tax

$(801)

$458

$(1,259)

$(290)

$(511)

Operating EBIT ¹

$(21)

$819

$(840)

$230

$(251)

Operating EBITDA ¹

$703

$1,501

$(798)

$944

$(241)

GAAP Earnings (Loss) Per Share

$(1.18)

$0.62

$(1.80)

$(0.44)

$(0.74)

Operating Earnings Per Share ¹

$(0.42)

$0.68

$(1.10)

$0.02

$(0.44)

Cash Provided by (Used for)
Operating Activities – Cont. Ops

$(470)

$832

$(1,302)

$104

$(574)








1.

Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin and Op. EBITDA, Free Cash Flow and Cash Flow Conversion are non-GAAP measures. See page 6 for further discussion.

®™ Trademark of The Dow Chemical Company or an affiliated company of Dow  

SEGMENT HIGHLIGHTS

Packaging & Specialty Plastics


Three Months Ended Jun 30

Three Months Ended Mar 31

In millions

2Q25

2Q24

vs. SQLY

[B / (W)]

 1Q25

vs. PQ

[B / (W)]

Net Sales

$5,025

$5,515

$(490)

$5,310

$(285)

Operating EBIT

$71

$703

$(632)

$342

$(271)

Equity Earnings (Losses)

$7

$55

$(48)

$39

$(32)

Packaging & Specialty Plastics segment net sales in the quarter were $5 billion, down 9% versus the year-ago period1. Local price decreased 10% year-over-year, primarily driven by lower downstream polymer prices. Currency increased net sales by 1%. Volume increased 1% year-over-year, driven by higher energy sales and polyethylene volumes, partly offset by lower volumes in functional polymers. On a sequential basis, net sales declined, primarily driven by lower merchant ethylene sales. This was the result of the start-up of Poly-7, which will lead to a balanced ethylene position in the U.S. Gulf Coast, driving margin uplift through full downstream integration.

Equity earnings were $7 million, a decrease of $48 million compared to the prior year, due to lower integrated margins at our principal joint ventures. Sequentially, equity earnings decreased by $32 million, primarily driven by higher losses at Sadara and the Thai joint ventures.

Op. EBIT was $71 million, a decrease of $632 million compared to the year-ago period, primarily driven by lower integrated margins. Sequentially, Op. EBIT decreased by $271 million, notably due to lower integrated margins and operating rates on top of higher planned maintenance.

Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, driven by lower downstream polymer prices, the impact of the laminating adhesives business divestiture1, and lower demand for infrastructure applications. Sequentially, net sales decreased, as higher demand for flexible and rigid packaging was more than offset by lower licensing revenue and polyethylene prices, weighed down by tariff uncertainties.

Hydrocarbons & Energy business reported a net sales decrease compared to the year-ago period, driven by lower aromatics prices, partly offset by higher energy sales. Sequentially, net sales decreased, driven by lower merchant ethylene sales, primarily from the start-up of Poly-7.   

1.

Includes a 1% unfavorable impact from the sale of the flexible packaging laminating adhesives business in the fourth quarter of 2024 which is presented as "Portfolio & Other" in the Sales Variances by Segment and Geographic Region table on page 10.

Industrial Intermediates & Infrastructure  

Three Months Ended Jun 30

Three Months Ended Mar 31

In millions

2Q25

2Q24

vs. SQLY

[B / (W)]

1Q25

vs. PQ

[B / (W)]

Net Sales

$2,786

$2,951

$(165)

$2,855

$(69)

Operating EBIT

$(185)

$7

$(192)

$(128)

$(57)

Equity Earnings (Losses)

$(39)

$(31)

$(8)

$(58)

$19

Industrial Intermediates & Infrastructure segment net sales were $2.8 billion, down 6% versus the year-ago period. Local price declined 5% year-over-year, reflecting declines in both businesses. Currency increased net sales by 1%. Volume decreased 2% year-over-year, driven by lower volumes in Polyurethanes & Construction Chemicals, partly offset by higher volumes in Industrial Solutions. On a sequential basis, net sales decreased 2% as the seasonally lower deicing fluids volume was partially offset by currency tailwinds and a lower-than-typical seasonal improvement in demand for building & construction applications.

Equity losses for the segment were $39 million, compared to equity losses of $31 million in the year-ago period, primarily driven by lower MEG margins at the Kuwait joint ventures. Equity losses in the prior quarter were $58 million. Sequentially, equity losses improved by $19 million, driven by higher operating rates at Sadara.

Op. EBIT decreased $192 million versus the year-ago period, driven by lower prices in both businesses and higher planned maintenance activity. On a sequential basis, Op. EBIT decreased by $57 million, driven by lower volume, higher planned maintenance activity, and activities related to the startup of our Alkoxylation unit in Seadrift, TX, which has now reached mechanical completion.

Polyurethanes & Construction Chemicals business reported a decrease in net sales compared to the year-ago period, driven by lower volume and price in EMEAI. Sequentially, net sales were flat as currency tailwinds and modest seasonal improvements in demand for building & construction applications were offset by lower demand in mobility applications.

Industrial Solutions business reported a decrease in net sales compared to the year-ago period, primarily driven by lower local prices, which were partially offset by higher demand for energy applications. Sequentially, net sales declined, driven by typical declines in demand for deicing fluids following the winter months.

Performance Materials & Coatings


Three Months Ended Jun 30

Three Months Ended Mar 31

In millions

2Q25

2Q24

vs. SQLY

[B / (W)]

1Q25

vs. PQ

[B / (W)]

Net Sales

$2,129

$2,243

$(114)

$2,071

$58

Operating EBIT

$152

$146

$6

$49

$103

Equity Earnings (Losses)

$1

$2

$(1)

$0

$1

Performance Materials & Coatings segment net sales in the quarter were $2.1 billion, down 5% versus the year-ago period. Local price decreased 3% year-over-year, driven by declines in both businesses. Currency increased net sales by 1%. Volume was down 3% year-over-year, as volume gains in downstream silicones were more than offset by lower volumes for coatings applications and in upstream siloxanes. On a sequential basis, net sales were up 3% with gains in both businesses, driven by seasonally higher demand for architectural coatings and higher downstream silicones volumes.

Op. EBIT increased $6 million versus the year-ago period, driven by margin expansion from lower input costs, which were partly offset by lower volumes. Sequentially, Op. EBIT increased $103 million, driven by lower input costs and volume gains in both businesses, from both seasonal improvements and continued downstream silicones growth, as well as lower fixed costs.

Consumer Solutions business reported a decrease in net sales versus the year-ago period, as downstream silicones volume gains were more than offset by both lower prices and lower upstream siloxanes volumes. Sequentially, net sales increased, driven by higher demand for downstream silicones, led by mobility, personal care and industrial applications.

Coatings & Performance Monomers business reported a decrease in net sales compared to the year-ago period, driven by lower demand for coatings applications, as the housing market continues to be challenged. Sequentially, net sales increased, driven by seasonally higher demand for architectural coatings, partly offset by lower acrylic monomers volumes.

OUTLOOK

"Dow's strategic actions enable us to mitigate the dynamic factors that our industry is facing. However, signs of oversupply from newer market entrants who are exporting to various regions at anti-competitive economics require broader industry engagement and additional regulatory action to restore competitive dynamics," said Fitterling. "The commissioning of our near-term growth projects, which are all operational in the third quarter, paired with our longer-term strategic investments, will increase Dow's position in higher-value applications and attractive end markets that are not exposed to this same level of anti-competitive activity. This will enable more resilient earnings and leading shareholder returns. Additionally, Team Dow is focused on structurally improving our cost base, optimizing our global asset footprint, and maintaining our track record of operational excellence to further strengthen our competitive advantages."

Conference Call

Dow will host a live webcast of its quarterly earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

About Dow

Dow (NYSE: DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, focused innovation, leading business positions and commitment to sustainability enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 30 countries and employ approximately 36,000 people. Dow delivered sales of approximately $43 billion in 2024. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us and our ambition to be the most innovative, customer-centric, inclusive and sustainable materials science company in the world by visiting www.dow.com.

Cautionary Statement about Forward-Looking Statements 

Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow's products and services and ability to compete in such markets; Dow's ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow's information technology networks and systems, including the impact of cyberattacks; risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and the Company's subsequent Quarterly Reports on Form 10-Q. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

®TM Trademark of The Dow Chemical Company or an affiliated company of Dow   

Non-GAAP Financial Measures

This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.

Operating Earnings Per Share is defined as "Earnings (loss) per common share - diluted" excluding the after-tax impact of significant items.

Operating EBIT is defined as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items.

Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

Operating EBITDA is defined as earnings (i.e., "Income (loss) before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Free Cash Flow is defined as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

Cash Flow Conversion is defined as "Cash provided by (used for) operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

Dow Inc. and Subsidiaries

Consolidated Statements of Income

 

In millions, except per share amounts (Unaudited)

Three Months Ended

Six Months Ended

Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Net sales

$   10,104

$   10,915

$   20,535

$   21,680

Cost of sales

9,521

9,591

19,281

19,079

Research and development expenses

188

196

388

400

Selling, general and administrative expenses

347

390

713

832

Amortization of intangibles

63

77

139

158

Restructuring and asset related charges - net

591

—

799

45

Equity in earnings (losses) of nonconsolidated affiliates

(30)

26

(50)

43

Sundry income (expense) - net

147

76

160

137

Interest income

39

42

67

107

Interest expense and amortization of debt discount

209

197

425

396

Income (loss) before income taxes

(659)

608

(1,033)

1,057

Provision for income taxes

142

150

58

61

Net income (loss)

(801)

458

(1,091)

996

Net income attributable to noncontrolling interests

34

19

51

41

Net income (loss) available for Dow Inc. common stockholders

$      (835)

$       439

$   (1,142)

$       955






Per common share data:





Earnings (loss) per common share - basic

$     (1.18)

$      0.62

$     (1.62)

$      1.35

Earnings (loss) per common share - diluted

$     (1.18)

$      0.62

$     (1.62)

$      1.35






Weighted-average common shares outstanding - basic

709.5

703.8

708.2

704.1

Weighted-average common shares outstanding - diluted

709.5

705.3

708.2

705.5

 

Dow Inc. and Subsidiaries

Consolidated Balance Sheets

 

In millions, except share amounts (Unaudited)

Jun 30,
2025

Dec 31,
2024

Assets



Current Assets



Cash and cash equivalents

$         2,399

$         2,189

Accounts and notes receivable:



Trade (net of allowance for doubtful receivables - 2025: $72; 2024: $95)

5,426

4,756

Other

2,228

2,108

Inventories

6,701

6,544

Other current assets

958

993

Total current assets (variable interest entities restricted - 2025: $209; 2024: $55)

17,712

16,590

Investments



Investment in nonconsolidated affiliates

1,262

1,266

Other investments (investments carried at fair value - 2025: $2,033; 2024: $2,047)

2,788

3,033

Noncurrent receivables

434

380

Total investments

4,484

4,679

Property



Property

64,860

62,121

Less: Accumulated depreciation

42,384

40,117

Net property (variable interest entities restricted - 2025: $2,380; 2024: $122)

22,476

22,004

Other Assets



Goodwill

8,698

8,565

Other intangible assets (net of accumulated amortization - 2025: $5,660; 2024: $5,394)

1,606

1,721

Operating lease right-of-use assets

1,246

1,268

Deferred income tax assets

1,424

1,257

Deferred charges and other assets

1,345

1,228

Total other assets (variable interest entities restricted - 2025: $212; 2024: $15)

14,319

14,039

Total Assets

$       58,991

$       57,312

Liabilities and Equity



Current Liabilities



Notes payable

$            149

$            135

Long-term debt due within one year

401

497

Accounts payable:



Trade

4,944

4,847

Other

1,697

1,694

Operating lease liabilities - current

325

318

Income taxes payable

314

276

Accrued and other current liabilities

2,656

2,521

Total current liabilities (variable interest entities nonrecourse - 2025: $365; 2024: $24)

10,486

10,288

Long-Term Debt (variable interest entities nonrecourse - 2025: $176; 2024: $—)

16,247

15,711

Other Noncurrent Liabilities



Deferred income tax liabilities

378

392

Pension and other postretirement benefits - noncurrent

4,765

4,736

Asbestos-related liabilities - noncurrent

665

713

Operating lease liabilities - noncurrent

982

984

Other noncurrent obligations

6,876

6,637

Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $329; 2024: $13)

13,666

13,462

Stockholders' Equity



Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

issued 2025: 785,942,132 shares; 2024: 784,471,939 shares)

8

8

Additional paid-in capital

10,758

9,203

Retained earnings

18,766

20,909

Accumulated other comprehensive loss

(7,826)

(8,110)

Treasury stock at cost (2025: 77,097,981 shares; 2024: 80,859,145 shares)

(4,475)

(4,655)

Dow Inc.'s stockholders' equity

17,231

17,355

Noncontrolling interests

1,361

496

Total equity

18,592

17,851

Total Liabilities and Equity

$       58,991

$       57,312

 

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows

 

In millions (Unaudited)

Six Months Ended

Jun 30,
2025

Jun 30,
2024

Operating Activities



Net income (loss)

$     (1,091)

$           996

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:



Depreciation and amortization

1,438

1,402

Provision (credit) for deferred income tax

(131)

28

Earnings of nonconsolidated affiliates less than dividends received

220

156

Net periodic pension benefit credit

(50)

(95)

Pension contributions

(76)

(63)

Net gain on sales of assets, businesses and investments

(102)

(20)

Restructuring and asset related charges - net

799

45

Other net loss

104

155

Changes in assets and liabilities, net of effects of acquired and divested companies:



Accounts and notes receivable

(935)

(485)

Inventories

(158)

(383)

Accounts payable

(12)

544

Other assets and liabilities, net

(372)

(988)

Cash provided by (used for) operating activities - continuing operations

(366)

1,292

Cash provided by (used for) operating activities - discontinued operations

(13)

8

Cash provided by (used for) operating activities

(379)

1,300

Investing Activities



Capital expenditures

(1,347)

(1,437)

Investment in gas field developments

(68)

(96)

Proceeds from sales of property, businesses and consolidated companies, net of cash divested

131

8

Investments in and loans to nonconsolidated affiliates

(20)

(4)

Purchases of investments

(205)

(1,072)

Proceeds from sales and maturities of investments

552

1,824

Other investing activities, net

(5)

12

Cash used for investing activities

(962)

(765)

Financing Activities



Changes in short-term notes payable

48

26

Proceeds from issuance of short-term debt greater than three months

37

40

Payments on short-term debt greater than three months

(41)

—

Proceeds from issuance of long-term debt

1,107

1,396

Payments on long-term debt

(1,114)

(183)

Collections on securitization programs, net of remittances

18

21

Purchases of treasury stock

—

(400)

Proceeds from issuance of stock

—

51

Transaction financing, debt issuance and other costs

(85)

(11)

Employee taxes paid for share-based payment arrangements

(16)

(38)

Distributions to noncontrolling interests

(56)

(47)

Proceeds from sale of noncontrolling interests

2,433

—

Dividends paid to stockholders

(990)

(984)

Cash provided by (used for) financing activities

1,341

(129)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

253

(69)

Summary



Increase in cash, cash equivalents and restricted cash

253

337

Cash, cash equivalents and restricted cash at beginning of period

2,263

3,048

Cash, cash equivalents and restricted cash at end of period

$       2,516

$       3,385

Less: Restricted cash and cash equivalents, included in "Other current assets"

117

44

Cash and cash equivalents at end of period

$       2,399

$       3,341

 

Dow Inc. and Subsidiaries

Net Sales by Segment and Geographic Region

 

Net Sales by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Packaging & Specialty Plastics

$     5,025

$     5,515

$   10,335

$   10,945

Industrial Intermediates & Infrastructure

2,786

2,951

5,641

5,959

Performance Materials & Coatings

2,129

2,243

4,200

4,395

Corporate

164

206

359

381

Total

$   10,104

$   10,915

$   20,535

$   21,680

U.S. & Canada

$     3,988

$     4,191

$     8,215

$     8,321

EMEAI 1

3,272

3,572

6,546

7,056

Asia Pacific

1,737

1,901

3,595

3,822

Latin America

1,107

1,251

2,179

2,481

Total

$   10,104

$   10,915

$   20,535

$   21,680

 

Net Sales Variance by
Segment and
Geographic Region

Three Months Ended Jun 30, 2025

Six Months Ended Jun 30, 2025


Local
Price &
Product
Mix

Currency

Volume

Portfolio
& Other 2

Total

Local
Price &
Product
Mix

Currency

Volume

Portfolio
& Other 2

Total


Percent change from prior year


Packaging & Specialty
  Plastics

(10) %

1 %

1 %

(1) %

(9) %

(7) %

— %

2 %

(1) %

(6) %


Industrial Intermediates &
  Infrastructure

(5)

1

(2)

—

(6)

(4)

—

(1)

—

(5)


Performance Materials &
  Coatings

(3)

1

(3)

—

(5)

(2)

—

(2)

—

(4)


Total

(7) %

1 %

(1) %

— %

(7) %

(5) %

— %

1 %

(1) %

(5) %


Total, excluding the
  Hydrocarbons & Energy
  business

(6) %

1 %

(2) %

(1) %

(8) %

(5) %

— %

— %

(1) %

(6) %


U.S. & Canada

(6) %

— %

2 %

(1) %

(5) %

(4) %

— %

3 %

— %

(1) %


EMEAI 1

(7)

2

(3)

—

(8)

(5)

—

(1)

(1)

(7)


Asia Pacific

(8)

1

(1)

(1)

(9)

(7)

—

1

—

(6)


Latin America

(8)

—

(3)

(1)

(12)

(8)

—

(4)

—

(12)


Total

(7) %

1 %

(1) %

— %

(7) %

(5) %

— %

1 %

(1) %

(5) %


 

Net Sales Variance by Segment and Geographic Region

Three Months Ended Jun 30, 2025


Local
Price &
Product
Mix

Currency

Volume

Total


Percent change from prior quarter


Packaging & Specialty Plastics

(5) %

2 %

(2) %

(5) %


Industrial Intermediates & Infrastructure

(1)

2

(3)

(2)


Performance Materials & Coatings

—

1

2

3


Total

(3) %

2 %

(2) %

(3) %


Total, excluding the Hydrocarbons & Energy business

(2) %

2 %

(1) %

(1) %


U.S. & Canada

(4) %

— %

(2) %

(6) %


EMEAI 1

(2)

5

(3)

—


Asia Pacific

(2)

1

(6)

(7)


Latin America

(3)

—

6

3


Total

(3) %

2 %

(2) %

(3) %


  1. Europe, Middle East, Africa and India.
  2. Portfolio & Other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the fourth quarter of 2024.

 

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures

 

Operating EBIT by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Packaging & Specialty Plastics


$         71

$       703

$       413

$     1,308

Industrial Intermediates & Infrastructure


(185)

7

(313)

94

Performance Materials & Coatings


152

146

201

187

Corporate


(59)

(37)

(92)

(96)

Total


$        (21)

$       819

$       209

$     1,493







Depreciation and Amortization by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Packaging & Specialty Plastics


$       369

$       343

$       729

$       714

Industrial Intermediates & Infrastructure


153

141

299

288

Performance Materials & Coatings


192

191

392

384

Corporate


10

7

18

16

Total


$       724

$       682

$     1,438

$     1,402







Operating EBITDA by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Packaging & Specialty Plastics


$       440

$     1,046

$     1,142

$     2,022

Industrial Intermediates & Infrastructure


(32)

148

(14)

382

Performance Materials & Coatings


344

337

593

571

Corporate


(49)

(30)

(74)

(80)

Total


$       703

$     1,501

$     1,647

$     2,895







Equity in Earnings (Losses) of Nonconsolidated
Affiliates by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Packaging & Specialty Plastics


$           7

$         55

$         46

$         80

Industrial Intermediates & Infrastructure


(39)

(31)

(97)

(46)

Performance Materials & Coatings


1

2

1

8

Corporate


1

—

—

1

Total


$        (30)

$         26

$        (50)

$         43







Reconciliation of "Net income (loss)" to "Operating

Three Months Ended

Six Months Ended

In millions (Unaudited)

Mar 31,
2025

Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Net income (loss)

$      (290)

$      (801)

$       458

$   (1,091)

$       996

+ Provision (credit) for income taxes

(84)

142

150

58

61

Income (loss) before income taxes

$      (374)

$      (659)

$       608

$   (1,033)

$     1,057

-  Interest income

28

39

42

67

107

+ Interest expense and amortization of debt discount

216

209

197

425

396

-  Significant items

(416)

(468)

(56)

(884)

(147)

Operating EBIT (non-GAAP)

$       230

$        (21)

$       819

$       209

$     1,493

 

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures

 

Significant Items Impacting Results for the Three Months Ended Jun 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$    (659)

$    (835)

$   (1.18)


Less: Significant items





2025 Restructuring Program severance
  and related benefit costs and asset
  related charges 4

(591)

(474)

(0.67)

Restructuring and asset related charges
- net

Implementation costs 5

(5)

(4)

(0.01)

Cost of sales ($1 million);

SG&A ($4 million)

Net gain on divestitures and asset sale 6

103

77

0.11

Sundry income (expense) - net

Litigation related charges, awards and
  adjustments 7

42

33

0.05

Cost of sales

Indemnification and other transaction 
  related costs 8

(17)

(17)

(0.02)

Sundry income (expense) - net

Income tax related items 9

—

(153)

(0.22)

Provision for income taxes

Total significant items

$    (468)

$    (538)

$   (0.76)


Operating results (non-GAAP)

$    (191)

$    (297)

$   (0.42)


 

Significant Items Impacting Results for the Three Months Ended Jun 30, 2024

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$      608

$      439

$     0.62


Less: Significant items





Restructuring, implementation and
  efficiency costs, and asset related
  charges - net 10

(56)

(43)

(0.06)

Cost of sales ($44 million);

R&D ($1 million); SG&A ($11 million)

Total significant items

$      (56)

$      (43)

$   (0.06)


Operating results (non-GAAP)

$      664

$      482

$     0.68


  1. "Income (loss) before income taxes."
  2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  4. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program.
  5. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's wholly owned subsidiary, Dow InfraCo, LLC.
  6. Related to a gain on the sale of the soil fumigation product line.
  7. Includes a gain associated with the reassessment of liabilities for certain accrued legacy agricultural products groundwater contamination matters, partially offset by the settlement of a separate claim related to water storage district legacy groundwater contamination matters.
  8. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
  9. Related to valuation allowances on deferred tax assets in certain foreign jurisdictions, partially offset by a tax basis adjustment related to the consolidated infrastructure entity.
  10. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program.

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures

 

Significant Items Impacting Results for the Six Months Ended Jun 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$ (1,033)

$ (1,142)

$   (1.62)


Less: Significant items





Restructuring, implementation and
  efficiency costs, and asset related
  charges - net 4

(51)

(39)

(0.05)

Cost of sales ($44 million);

R&D ($1 million); SG&A ($4 million);
Restructuring and asset related
charges - net ($1 million); Sundry
income (expense) - net ($1 million)

2025 Restructuring Program severance
  and related benefit costs and asset
  related charges 5

(798)

(635)

(0.90)

Restructuring and asset related charges
- net

Implementation costs 6

(5)

(4)

(0.01)

Cost of sales ($1 million);

SG&A ($4 million)

Net gain on divestitures and asset sale 7

103

77

0.11

Sundry income (expense) - net

Litigation related charges, awards and
  adjustments 8

42

33

0.05

Cost of sales

Loss on early extinguishment of debt

(60)

(48)

(0.07)

Sundry income (expense) - net

Indemnification and other transaction
  related costs 9

(115)

(93)

(0.13)

Cost of sales ($98 million); Sundry
income (expense) - net ($17 million)

Income tax related items 10

—

(153)

(0.22)

Provision for income taxes

Total significant items

$    (884)

$    (862)

$   (1.22)


Operating results (non-GAAP)

$    (149)

$    (280)

$   (0.40)


 

Significant Items Impacting Results for the Six Months Ended Jun 30, 2024

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   1,057

$      955

$     1.35


Less: Significant items





Restructuring, implementation and
  efficiency costs, and asset related
  charges - net 4

(147)

(115)

(0.16)

Cost of sales ($77 million);

R&D ($2 million); SG&A ($23 million);
Restructuring and asset related
charges - net ($45 million)

Income tax related items 10

—

194

0.27

Provision for income taxes

Total significant items

$    (147)

$       79

$     0.11


Operating results (non-GAAP)

$   1,204

$      876

$     1.24


  1. "Income (loss) before income taxes."
  2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  4. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partly offset by an asset related credit adjustment in 2025 and impairment charges related to the write-down of certain manufacturing assets in 2024.
  5. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program.
  6. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's wholly owned subsidiary, Dow InfraCo, LLC.
  7. Related to a gain on the sale of the soil fumigation product line..
  8. Includes a gain associated with the reassessment of liabilities for certain accrued legacy agricultural products groundwater contamination matters, partially offset by the settlement of a separate claim related to water storage district legacy groundwater contamination matters.
  9. Primarily Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. Also includes charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
  10. 2025 relates to valuation allowances on deferred tax assets in certain foreign jurisdictions, partially offset by a tax basis adjustment related to the consolidated infrastructure entity. 2024 relates to reassessment of interest and penalties related to a tax matter in a foreign jurisdiction.

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures

 

Significant Items Impacting Results for the Three Months Ended Mar 31, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net Income 2

EPS 3

Income Statement Classification

Reported results

$    (374)

$    (307)

$   (0.44)


Less: Significant items





Restructuring, implementation and
  efficiency costs, and asset related
  charges - net 4

(51)

(39)

(0.05)

Cost of sales ($44 million);

R&D ($1 million); SG&A ($4 million);
Restructuring and asset related
charges - net ($1 million); Sundry
income (expense) - net ($1 million)

2025 Restructuring Program 5

(207)

(161)

(0.23)

Restructuring and asset related charges
- net

Loss on early extinguishment of debt

(60)

(48)

(0.07)

Sundry income (expense) - net

Indemnification and other transaction
  related costs 6

(98)

(76)

(0.11)

Cost of sales

Total significant items

$    (416)

$    (324)

$   (0.46)


Operating results (non-GAAP)

$       42

$       17

$     0.02


  1. "Income (loss) before income taxes."
  2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  4. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The first quarter of 2025 also includes impairment charges related to the write-down of certain manufacturing assets, partly offset by an asset related credit adjustment. The first quarter of 2024 also includes impairment charges related to the write-down of certain manufacturing assets.
  5. Severance and related benefit costs associated with the Company's 2025 Restructuring Program.
  6. Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business.

Reconciliation of Free Cash Flow

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30,
2025

Jun 30,
2024

Jun 30,
2025

Jun 30,
2024

Cash provided by (used for) operating activities - continuing
  operations (GAAP)

$      (470)

$       832

$      (366)

$     1,292

Capital expenditures

(662)

(723)

(1,347)

(1,437)

Free Cash Flow (non-GAAP)

$   (1,132)

$       109

$   (1,713)

$      (145)

 

Reconciliation of Cash Flow Conversion

Three Months Ended

In millions (Unaudited)

Sep 30,
2024

Dec 31,
2024

Mar 31,
2025

Jun 30,
2025

Cash provided by (used for) operating activities - continuing
  operations (GAAP)

$    800

$    811

$    104

$   (470)

Net income (loss) (GAAP)

$    240

$     (35)

$   (290)

$   (801)

Cash flow from operations to net income (GAAP) 1

333.3 %

N/A

N/A

N/A

Cash flow from operations to net income - trailing twelve months (GAAP) 2


N/A

Operating EBITDA (non-GAAP)

$  1,382

$  1,205

$    944

$    703

Cash Flow Conversion (Cash flow from operations to Operating
  EBITDA) (non-GAAP)

57.9 %

67.3 %

11.0 %

(66.9) %

Cash Flow Conversion - trailing twelve months (non-GAAP)


29.4 %

  1. Cash flow from operations to net income is not applicable for the second quarter of 2025, first quarter of 2025 and fourth quarter of 2024 due to a net loss for the period.
  2. Cash flow from operations to net income - trailing twelve months is not applicable due to a net loss for the trailing twelve months period.

For further information, please contact:

Investors:

Andrew Riker

ajriker@dow.com

Media:

Sarah Young

syoung3@dow.com



X: https://twitter.com/DowNewsroom 
Facebook: https://www.facebook.com/dow/ 
LinkedIn: http://www.linkedin.com/company/dow-chemical 
Instagram: http://instagram.com/dow_official

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-second-quarter-2025-results-302513007.html

SOURCE The Dow Chemical Company